Science 37

Science 37's mission is to make clinical research accessible to anyone, anywhere, anytime by pioneering a decentralized clinical trial (DCT) model. Its key achievement is establishing a unique, FDA-inspected Direct-to-Patient Site, which has successfully supported over 185 trials and consistently ranks as a top-enrolling site. The company's strategy leverages its proprietary technology platform and a nationwide network of research-grade nurses to orchestrate hybrid and fully decentralized trials, offering sponsors a proven path to faster, more diverse patient recruitment and retention.

The NeuroMetasite™ is Science 37's proprietary, integrated technology platform that orchestrates the entire decentralized trial process, from patient recruitment and virtual site management to the dispatch of research-grade nurses and secure data capture.